Industry IQ – QumulusAI
Microsoft’s introduction of the Maia 200 adds to a growing list of hyperscaler-developed processors, alongside offerings from AWS and Google. These custom AI chips are largely designed to improve inference efficiency and optimize internal cost structures, though some platforms also support large-scale training. Google’s offering is currently the most mature, with a longer production…
Latest
Industry IQ - QumulusAI
OpenAI–Cerebras Deal Signals Selective Inference Optimization, Not Replacement of GPUs
OpenAI’s partnership with Cerebras has raised questions about the future of GPUs in inference workloads. Cerebras uses a wafer-scale architecture that places an entire cluster onto a single silicon chip. This design reduces communication overhead and is built to improve latency and throughput for large-scale inference. QumulusAI Senior Product Manager Mark Jackson says Cerebras’…
Industry IQ - QumulusAI
NVIDIA Rubin Brings 5x Inference Gains for Video and Large Context AI, Not Everyday Workloads
NVIDIA’s Rubin GPUs are expected to deliver a substantial increase in inference performance in 2026. The company claims up to 5 times the performance of B200s and B300s systems. These gains signal a major step forward in raw inference capability. Mark Jackson, Senior Product Manager at QumulusAI, explains that this level of performance is…
Latest
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…
Pursuing the Impossible: The New Space Race with Firefly Aerospace Co-Founder Eric Salwan
Many companies set out to do something hard. Firefly Aerospace set out to do the impossible. After 10 years and several existential moments, Firefly did what no private company ever had: in 2025, it successfully landed on the Moon. Before Firefly, only countries had ever landed on the Moon—and it took extraordinary national effort…
Tale of Two Interns: What AI Is Really Doing to Entry-Level Work
The narrative around early-career work has become increasingly pessimistic, with headlines pointing to a shrinking pool of entry-level roles, fewer internship opportunities, and AI accelerating both trends. But beneath that narrative, a different tension is emerging—one that’s less about the disappearance of opportunity and more about how it’s being reshaped. Students are using AI…
